SCHEMBL24614744

SCHEMBL24614744

Cc1cccc(-c2c3ccccc3c(B(O)O)c3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 3/20 0.42
CNR1 P21554 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TSHR P16473 2/20 0.38
HPGD P15428 2/20 0.38
ENPP1 P22413 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NR1I3 Q14994 2/20 0.37
KMT2A Q03164 1/20 0.37
ACHE P22303 2/20 0.37
PTPN5 P54829 1/20 0.36
ALDH1A1 P00352 2/20 0.35
ACLY P53396 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12926842 0.86 BRD9 (0.37) CNR2NPC1RAB9ATSHRACHE
SCHEMBL488939 0.85 ACHE (0.50) CNR2CNR1L3MBTL1NPC1RAB9A
SCHEMBL28674004 0.83 KDM4E (0.42) L3MBTL1NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL31238896 0.82 MGLL (0.50) KMT2A
SCHEMBL1527428 0.82 MGLL (0.50) KMT2A
SCHEMBL20809931 0.81 CNR1 (0.49) CNR2CNR1L3MBTL1NPC1RAB9A
SCHEMBL7487894 0.81 ACHE (0.46) CNR2CNR1L3MBTL1NPC1RAB9A
SCHEMBL16395160 0.80 ACHE (0.45) L3MBTL1TSHRSMN1; SMN2KMT2AACHE
SCHEMBL9612423 0.80 MAPK1 (0.43) CNR2CNR1L3MBTL1NPC1RAB9A
SCHEMBL338760 0.79 MGLL (0.43) L3MBTL1HPGDACHEALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223801-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES TMEM109, PIEZO1, L1CAM CNR2 4224/4885CNR1 3174/4885L3MBTL1 2463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.